How Netflix-style plans could solve drug-spending dilemmas
States are locked in a zero-sum budget game when it comes to breakthrough medical treatments. Subscription drug pricing can help.
Why putting prices in EHRs will help doctors keep costs in check
Including prescription-drug prices in electronic health records would improve transparency while simultaneously strengthening the patient-doctor bond.
Access to prescription drugs: How the doctor’s role is changing
The landscape for prescription medications continues to evolve. This is what physicians should know about the changes and strategies to improve access.
These are 2019’s most influential clinical executives
A leading health care trade publication has released its list of top 50 clinical executives. Twenty-one share a common trait: AMA membership.
New AMA president: Time for physicians to create history together
In ascending to one of medicine’s highest offices, new AMA president Patrice A. Harris, MD, MA, has completed an unlikely journey.
Time to scrutinize PBMs’ outsized role in Rx decision-making
The AMA calls for transparency and oversight of pharmacy benefit managers’ (PBM) operations.
AMA to Congress: Patients pay painful price for high drug costs
AMA leader tells of a patient who relies on an older drug that rose in price by 400% to about $80,000 a year. Share your stories to advance drug-pricing transparency.